aiqbench analysis
This paper introduces LiFUSE, a self-supervised pretraining framework designed to enhance liver disease detection on non-contrast CT scans by jointly modeling frequency and spatial information. By addressing the low tissue contrast inherent in these images, the method improves discriminative feature extraction for subtle hepatic lesions without requiring hemodynamic enhancement. The approach demonstrates robust performance across multiple clinical tasks, offering a practical solution for large-scale opportunistic screening where contrast agents are unavailable.
LiFUSE: Frequency-Spatial Unified Self-Supervised Pretraining for Liver Disease Analysis on Non-contrast CT
arXiv:2610.18243v1 Announce Type: cross Abstract: Given the growing global burden of liver tumors and diffuse liver diseases, non-contrast computed tomography (NCCT) is increasingly used for opportunistic screening because of its low cost and favorable safety profile. However, downstream tasks such as tumor detection and fine-grained disease diagnosis remain challenging due to NCCT's inherently low tissue contrast, lack of hemodynamic enhancement, and complex anatomical background. These limitations make subtle, heterogeneous, and multifocal hepatic lesions difficult to identify. Although large-scale self-supervised pretraining can learn robust representations from unlabeled NCCT scans, conventional voxel-wise reconstruction does not fully exploit the complementary information available in NCCT. Under weak NCCT contrast, low-level intensity patterns become less informative for pathology recognition, limiting the capture of lesion-specific discriminative features. In this paper, we propose the Liver Frequency-Spatial Unified Self-Supervised Pretraining (LiFUSE). The frequency branch applies random band-stop masking and spectrum reconstruction to encourage the model to capture subtle differences between lesions and surrounding tissues, while the spatial branch performs hybrid-granularity masked volumetric reconstruction to accommodate lesions of diverse sizes and morphologies. Finally, a cross-domain consistency scheme couples the spatial and frequency branches, yielding more discriminative representations for hepatic structures and lesions. Extensive experiments on three clinically relevant tasks across internal cohorts and a public target-domain transfer setting show that LiFUSE consistently outperforms strong baselines. These results suggest that unified frequency-spatial learning can improve liver disease analysis on NCCT, highlighting its potential for large-scale screening.
Abstract:Given the growing global burden of liver tumors and diffuse liver diseases, non-contrast computed tomography (NCCT) is increasingly used for opportunistic screening because of its low cost and favorable safety profile. However, downstream tasks such as tumor detection and fine-grained disease diagnosis remain challenging due to NCCT's inherently low tissue contrast, lack of hemodynamic enhancement, and complex anatomical background. These limitations make subtle, heterogeneous, and multifocal hepatic lesions difficult to identify. Although large-scale self-supervised pretraining can learn robust representations from unlabeled NCCT scans, conventional voxel-wise reconstruction does not fully exploit the complementary information available in NCCT. Under weak NCCT contrast, low-level intensity patterns become less informative for pathology recognition, limiting the capture of lesion-specific discriminative features. In this paper, we propose the Liver Frequency-Spatial Unified Self-Supervised Pretraining (LiFUSE). The frequency branch applies random band-stop masking and spectrum reconstruction to encourage the model to capture subtle differences between lesions and surrounding tissues, while the spatial branch performs hybrid-granularity masked volumetric reconstruction to accommodate lesions of diverse sizes and morphologies. Finally, a cross-domain consistency scheme couples the spatial and frequency branches, yielding more discriminative representations for hepatic structures and lesions. Extensive experiments on three clinically relevant tasks across internal cohorts and a public target-domain transfer setting show that LiFUSE consistently outperforms strong baselines. These results suggest that unified frequency-spatial learning can improve liver disease analysis on NCCT, highlighting its potential for large-scale screening.
Computer Vision and Pattern Recognition (cs.CV); Artificial Intelligence (cs.AI); Machine Learning (cs.LG)
arXiv:2610.18243 [cs.CV]
(or arXiv:2610.18243v1 [cs.CV] for this version)
https://doi.org/10.48550/arXiv.2610.18243 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 334 words
Related coverage
MR-JEPA: A General Purpose Video Foundation Model for Cardiac MRI
arXiv · Sep 1, 2026
X-Restormer++: 1st Place Solution for the UG2+ CVPR 2026 All-Weather Restoration Challenge
arXiv · Jun 3, 2026
SG-WAM: Self-Guided World Modeling in Geometry-Aware Policy Space
arXiv · Aug 4, 2026
Bridging Vision Foundation Model Priors with CLIP for Spatial-aware Few-shot Anomaly Detection in Medical Images
arXiv · Sep 14, 2026